Predicting single-cell perturbation responses for unseen drugs
  Single-cell transcriptomics enabled the study of cellular heterogeneity in
response to perturbations at the resolution of individual cells. However,
scaling high-throughput screens (HTSs) to measure cellular responses for many
drugs remains a challenge due to technical limitations and, more importantly,
the cost of such multiplexed experiments. Thus, transferring information from
routinely performed bulk RNA-seq HTS is required to enrich single-cell data
meaningfully. We introduce a new encoder-decoder architecture to study the
perturbational effects of unseen drugs. We combine the model with a transfer
learning scheme and demonstrate how training on existing bulk RNA-seq HTS
datasets can improve generalisation performance. Better generalisation reduces
the need for extensive and costly screens at single-cell resolution. We
envision that our proposed method will facilitate more efficient experiment
designs through its ability to generate in-silico hypotheses, ultimately
accelerating targeted drug discovery.
